Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Colombo

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Therapeutic Advances in Medical Oncology|September 15, 2025
Lenvatinib in advanced thyroid, salivary gland, endometrial, and hepatocellular carcinomas: a real-world study on treatment duration and toxicity managementElena Colombo, Monika Ducceschi, Stefano Cavalieri, et al.
Human Molecular Genetics|May 27, 2005
CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndromeFrancesca Mari, Sara Azimonti, Ilaria Bertani, et al.
Translational Oncology|December 18, 2020
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort studyEdoardo Francini, Fang-Shu Ou, Stefano Lazzi, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2025
Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trialPaolo Bossi, Andrea Alberti, Cristiana Bergamini, et al.
Journal of Clinical Medicine|August 6, 2020
Differential Diagnosis and Management of Diarrhea in Patients with Neuroendocrine TumorsSara Pusceddu, Roberta Elisa Rossi, Martina Torchio, et al.
Clinical Lung Cancer|February 23, 2021
Recent Advances in the Management of Typical and Atypical Lung CarcinoidsNatalie Prinzi, Roberta Elisa Rossi, Claudia Proto, et al.
Head & Neck|March 4, 2025
Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian CentersFrancesca Caspani, Stefano Cavalieri, Ester Orlandi, et al.
Oral Oncology|October 1, 2023
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experienceStefano Cavalieri, Francesca Platini, Francesco Barretta, et al.
Cells|January 11, 2022
Immunotherapy in Nonendemic Nasopharyngeal Carcinoma: Real-World Data from Two Nonendemic RegionsPanagiota Economopoulou, Anastasios Pantazopoulos, Aris Spathis, et al.
European Journal of Cancer (Oxford, England : 1990)|July 29, 2025
Longitudinal assessment of plasma EBV-DNA in non-endemic EBV-related nasopharyngeal cancer (NPC): the LEA studySalvatore Alfieri, Rebecca RomanĂ², Sara Marceglia, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Therapeutic Advances in Medical Oncology|September 15, 2025
Lenvatinib in advanced thyroid, salivary gland, endometrial, and hepatocellular carcinomas: a real-world study on treatment duration and toxicity managementElena Colombo, Monika Ducceschi, Stefano Cavalieri, et al.
Human Molecular Genetics|May 27, 2005
CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndromeFrancesca Mari, Sara Azimonti, Ilaria Bertani, et al.
Translational Oncology|December 18, 2020
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort studyEdoardo Francini, Fang-Shu Ou, Stefano Lazzi, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2025
Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trialPaolo Bossi, Andrea Alberti, Cristiana Bergamini, et al.
Journal of Clinical Medicine|August 6, 2020
Differential Diagnosis and Management of Diarrhea in Patients with Neuroendocrine TumorsSara Pusceddu, Roberta Elisa Rossi, Martina Torchio, et al.
Clinical Lung Cancer|February 23, 2021
Recent Advances in the Management of Typical and Atypical Lung CarcinoidsNatalie Prinzi, Roberta Elisa Rossi, Claudia Proto, et al.
Head & Neck|March 4, 2025
Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian CentersFrancesca Caspani, Stefano Cavalieri, Ester Orlandi, et al.
Oral Oncology|October 1, 2023
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experienceStefano Cavalieri, Francesca Platini, Francesco Barretta, et al.
Cells|January 11, 2022
Immunotherapy in Nonendemic Nasopharyngeal Carcinoma: Real-World Data from Two Nonendemic RegionsPanagiota Economopoulou, Anastasios Pantazopoulos, Aris Spathis, et al.
European Journal of Cancer (Oxford, England : 1990)|July 29, 2025
Longitudinal assessment of plasma EBV-DNA in non-endemic EBV-related nasopharyngeal cancer (NPC): the LEA studySalvatore Alfieri, Rebecca RomanĂ², Sara Marceglia, et al.
Pageof 9